BR112018000522A2 - processo para produzir gema de ovo com alto teor de af-16 - Google Patents
processo para produzir gema de ovo com alto teor de af-16Info
- Publication number
- BR112018000522A2 BR112018000522A2 BR112018000522-3A BR112018000522A BR112018000522A2 BR 112018000522 A2 BR112018000522 A2 BR 112018000522A2 BR 112018000522 A BR112018000522 A BR 112018000522A BR 112018000522 A2 BR112018000522 A2 BR 112018000522A2
- Authority
- BR
- Brazil
- Prior art keywords
- egg yolk
- egg
- seq
- relates
- producing
- Prior art date
Links
- 102000002322 Egg Proteins Human genes 0.000 title abstract 7
- 108010000912 Egg Proteins Proteins 0.000 title abstract 7
- 210000002969 egg yolk Anatomy 0.000 title abstract 6
- 235000013345 egg yolk Nutrition 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 2
- 108010038288 antisecretory factor Proteins 0.000 abstract 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract 1
- 241000271566 Aves Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000014103 egg white Nutrition 0.000 abstract 1
- 210000000969 egg white Anatomy 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- 230000008020 evaporation Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 238000002386 leaching Methods 0.000 abstract 1
- 238000005374 membrane filtration Methods 0.000 abstract 1
- 239000004466 pelleted feed Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/20—Addition of proteins, e.g. hydrolysates, fats, carbohydrates, natural plant hydrocolloids; Addition of animal or vegetable substances containing proteins, fats, or carbohydrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Abstract
?processo para produzir gema de ovo com alto teor de af-16? a presente invenção refere-se a um processo para produzir uma gema de ovo com um teor muito elevado de proteínas do fator antissecretório (af), em particular com um teor muito elevado de fragmento de proteína af que consiste essencialmente na sequência de aminoácidos como mostrado no id.seq.no.1 (af-16) e/ou no id seq.no.2 (af-8), compreendendo o referido processo durante pelo menos 4 semanas alimentando uma ave, como uma galinha, uma alimentação peletizada por indução de af-16 para aves compreendendo pelo menos 0,14% de triptofano livre, como 1-2 g de triptofano/kg de alimento e, posteriormente, colhendo ovo das referidas aves, separando a gema de ovo da clara de ovo e alternativamente com secagem por pulverização, trituração, lixiviação, extração, evaporação, filtração de membrana e/ou liofilização da gema de ovo. a presente invenção refere-se ainda à referida gema de ovo com um teor muito elevado de proteínas do fator antissecretório (af), produzidos de acordo com o processo aqui descrito e à utilização para a preparação de produtos alimentícios funcionais e produtos farmacêuticos para o tratamento e profilaxia de condições fisiológicas anormais causadas, por exemplo, por níveis excepcionalmente elevados de evacuação de fluido corporal. a invenção também se refere a produtos alimentícios e produtos farmacêuticos assim preparados.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1551018 | 2015-07-10 | ||
SE1551018-3 | 2015-07-10 | ||
PCT/EP2016/064114 WO2017009004A1 (en) | 2015-07-10 | 2016-06-20 | Process for producing egg yolk with high content of af-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018000522A2 true BR112018000522A2 (pt) | 2018-09-18 |
Family
ID=56134371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018000522-3A BR112018000522A2 (pt) | 2015-07-10 | 2016-06-20 | processo para produzir gema de ovo com alto teor de af-16 |
Country Status (15)
Country | Link |
---|---|
US (1) | US11253552B2 (pt) |
EP (1) | EP3319618B1 (pt) |
JP (1) | JP6707121B2 (pt) |
KR (1) | KR20180027582A (pt) |
CN (1) | CN107949392B (pt) |
AU (1) | AU2016293344B2 (pt) |
BR (1) | BR112018000522A2 (pt) |
CA (1) | CA2992057C (pt) |
ES (1) | ES2887086T3 (pt) |
HK (1) | HK1247554A1 (pt) |
IL (1) | IL256566A (pt) |
MX (1) | MX2018000069A (pt) |
RU (1) | RU2723097C1 (pt) |
WO (1) | WO2017009004A1 (pt) |
ZA (1) | ZA201800095B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3813866A1 (en) | 2018-06-28 | 2021-05-05 | Lantmännen Medical AB | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
CN112770643A (zh) | 2018-09-28 | 2021-05-07 | 兰特门内保健食品公司 | 包含麦芽化脱壳燕麦的可消耗产品 |
WO2020160113A1 (en) * | 2019-02-01 | 2020-08-06 | Myos Rens Technology Inc. | Egg yolk powder for improving quality of life and increasing activity in aging and chronically ill mammals |
US20240099342A1 (en) * | 2019-10-31 | 2024-03-28 | Myos Corp. | Muscle enhancing products |
US20230096303A1 (en) | 2020-03-26 | 2023-03-30 | Lantmännen Functional Foods Ab | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02211831A (ja) * | 1989-02-10 | 1990-08-23 | Showa Denko Kk | 鶏卵のハウユニットの向上方法 |
JPH02211832A (ja) * | 1989-02-10 | 1990-08-23 | Showa Denko Kk | 鶏卵の卵殻強度の向上方法 |
SE466331B (sv) * | 1990-01-04 | 1992-02-03 | Svenska Lantmaennens | Saett att korrigera och optimera naeringssammansaettningen i foeda |
SE508609C2 (sv) * | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
SE9604251L (sv) | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
US6112143A (en) | 1998-08-06 | 2000-08-29 | Caterpillar Inc. | Method and apparatus for establishing a perimeter defining an area to be traversed by a mobile machine |
SE513496C2 (sv) | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
WO2002063948A2 (en) | 2001-02-14 | 2002-08-22 | The Lauridsen Group Incorporated | Poultry feed supplement for increasing poultry-based meat weight |
GB0322645D0 (en) | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
SG171601A1 (en) | 2006-04-27 | 2011-06-29 | Lantmaennen As Faktor Ab | Further medical uses of antisecretory protein |
CA2650132C (en) | 2006-04-27 | 2017-10-24 | Hans-Arne Hansson | Modulation of lipid rafts |
CN102633863B (zh) * | 2006-04-27 | 2014-08-06 | 兰特门内阿斯-法克托尔公司 | 抗分泌因子对于治疗高眼压的应用 |
JP5820277B2 (ja) | 2009-02-11 | 2015-11-24 | ラントメネン・アーエス−ファクトール・アーベー | 細胞取込を最適化するための抗分泌性因子(af)の使用 |
ES2680551T3 (es) | 2012-12-20 | 2018-09-10 | Lantmännen As-Faktor Ab | Factor antisecretor (AF) para el uso en el tratamiento del glioblastoma |
-
2016
- 2016-06-20 WO PCT/EP2016/064114 patent/WO2017009004A1/en active Application Filing
- 2016-06-20 RU RU2018104805A patent/RU2723097C1/ru active
- 2016-06-20 AU AU2016293344A patent/AU2016293344B2/en active Active
- 2016-06-20 ES ES16729926T patent/ES2887086T3/es active Active
- 2016-06-20 CA CA2992057A patent/CA2992057C/en active Active
- 2016-06-20 KR KR1020187004117A patent/KR20180027582A/ko active Search and Examination
- 2016-06-20 BR BR112018000522-3A patent/BR112018000522A2/pt not_active Application Discontinuation
- 2016-06-20 CN CN201680040903.XA patent/CN107949392B/zh active Active
- 2016-06-20 US US15/741,627 patent/US11253552B2/en active Active
- 2016-06-20 EP EP16729926.2A patent/EP3319618B1/en active Active
- 2016-06-20 MX MX2018000069A patent/MX2018000069A/es unknown
- 2016-06-20 JP JP2018500699A patent/JP6707121B2/ja active Active
-
2017
- 2017-12-25 IL IL256566A patent/IL256566A/en unknown
-
2018
- 2018-01-05 ZA ZA2018/00095A patent/ZA201800095B/en unknown
- 2018-05-25 HK HK18106894.4A patent/HK1247554A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MX2018000069A (es) | 2018-03-16 |
JP2018531214A (ja) | 2018-10-25 |
ZA201800095B (en) | 2018-12-19 |
CA2992057C (en) | 2021-07-20 |
AU2016293344B2 (en) | 2019-01-31 |
RU2723097C1 (ru) | 2020-06-08 |
CA2992057A1 (en) | 2017-01-19 |
US11253552B2 (en) | 2022-02-22 |
IL256566A (en) | 2018-02-28 |
CN107949392B (zh) | 2022-10-11 |
EP3319618A1 (en) | 2018-05-16 |
US20190231825A1 (en) | 2019-08-01 |
JP6707121B2 (ja) | 2020-06-10 |
AU2016293344A1 (en) | 2018-01-18 |
CN107949392A (zh) | 2018-04-20 |
ES2887086T3 (es) | 2021-12-21 |
HK1247554A1 (zh) | 2018-09-28 |
WO2017009004A1 (en) | 2017-01-19 |
KR20180027582A (ko) | 2018-03-14 |
EP3319618B1 (en) | 2021-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018000522A2 (pt) | processo para produzir gema de ovo com alto teor de af-16 | |
Qaisrani et al. | Threonine in broiler diets: an updated review | |
Balev et al. | Application of natural dietary antioxidants in broiler feeds. | |
UA118693C2 (uk) | Спосіб вирощування молодих курчат | |
RU2019137459A (ru) | Вакцины на основе реовирусов птиц | |
Krishnan | A comparative study on carcass yield in male and female Japanese quail (Coturnix coturnix japonica). | |
RO130418A8 (ro) | Producerea şi utilizarea ovotransferinei pc2 () | |
RU2566450C1 (ru) | Кормовая добавка для цыплят-бройлеров | |
Catania et al. | Isolation of Mycoplasma iowae in commercial turkey flocks | |
Petracci et al. | Pre-slaughter factors affecting mortality, live weight loss, and carcass quality in broiler chickens. | |
RU2601593C1 (ru) | Способ обработки инкубационных яиц | |
RU2540570C1 (ru) | Способ повышения вывода и жизнеспособности цыплят | |
Viana | RESPONSES TO REDUCTION ON DIETARY CRUDE PROTEIN AND SUPLEMENTATION OF NON-ESSENTIAL NITROGEN; DIETARY ESSENTIAL TO NON-ESSENTIAL NITROGEN OPTIMUM RATIO FOR WHITE COMMERCIAL LAYERS | |
RU2304398C2 (ru) | Способ повышения продуктивности птицы | |
Cordeiro | Eggshell membrane proteins provide innate immune protection | |
RU2798343C1 (ru) | Способ повышения качества мяса цыплят-бройлеров | |
BR112015025288A2 (pt) | vacina de campylobacter | |
Silva-Vázquez et al. | Mexican orégano (Lippia berlandieri Schauer) oil on turkey slaughter quality | |
Fernandes et al. | Effect of oral dietary supplement for chicks subjected to thermal oscillation on performance and intestinal morphometry | |
BR112018010202A2 (pt) | método para a criação de aves | |
Hemmati et al. | Journal of Animal Environment | |
LARGE et al. | Selected highlights from other journals | |
Jungbauer et al. | A phytogenic feed additive improves egg shell quality and tibia breaking strength in 90 weeks old laying hens | |
GR1008892B (el) | Χρηση ελαιολαδου για την παρασκευη σιτηρεσιου, καταλληλου για τη διατροφη κρεοπαραγωγων χοιρων, με σκοπο την αυξηση των αποδοσεων τους σε κρεας | |
Wangyuan et al. | Effect of Total Flavonoids of Rhizoma drynariae on Tibial Dyschondroplasia by Regulating BMP-2 and Runx2 Expression in Chickens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |